These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 31596999

  • 21. Lower Incidence of Cervical Intraepithelial Neoplasia among Young Women with Human Papillomavirus Vaccination in Miyagi, Japan.
    Ozawa N, Ito K, Tase T, Shibuya D, Metoki H, Yaegashi N.
    Tohoku J Exp Med; 2017 Dec; 243(4):329-334. PubMed ID: 29269635
    [Abstract] [Full Text] [Related]

  • 22. Monitoring the impact of a national HPV vaccination program in Japan (MINT Study): rationale, design and methods.
    Matsumoto K, Yaegashi N, Iwata T, Ariyoshi K, Fujiwara K, Shiroyama Y, Usami T, Kawano Y, Horie K, Kawano K, Noda K, Yoshikawa H, MINT Study Group.
    Jpn J Clin Oncol; 2014 Oct; 44(10):1000-3. PubMed ID: 25098705
    [Abstract] [Full Text] [Related]

  • 23. HPV16 and HPV18 genotyping triage in young women with borderline cytology or mild dyskaryosis: effect of age on genotype-specific risk of high-grade CIN.
    McKenna M, McMenamin M, McDowell A.
    Cytopathology; 2016 Aug; 27(4):261-8. PubMed ID: 26873051
    [Abstract] [Full Text] [Related]

  • 24. HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives.
    Castellsagué X, Schneider A, Kaufmann AM, Bosch FX.
    Gynecol Oncol; 2009 Dec; 115(3 Suppl):S15-23. PubMed ID: 19819540
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cervical intraepithelial neoplasia grade 2 or worse in Galicia, Spain: HPV 16 prevalence and vaccination impact.
    Pérez-Castro S, Lorenzo-Mahía Y, Iñarrea Fernández A, Lamas-González MJ, Sarán-Díez MT, Rubio-Alarcón J, Reboredo-Reboredo MC, Mosteiro-Lobato S, López-Miragaya I, Torres-Piñón J, Melón-García S.
    Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):479-85. PubMed ID: 24274937
    [Abstract] [Full Text] [Related]

  • 32. Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial.
    Monsonego J, Cox JT, Behrens C, Sandri M, Franco EL, Yap PS, Huh W.
    Gynecol Oncol; 2015 Apr; 137(1):47-54. PubMed ID: 25667973
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. HPV vaccination status and effectiveness in Korean women with HPV16/18 infection (2010-2021): a retrospective study.
    Na YJ, Jeong O, Seong J, Lee J, Lee SY, Hur S, Ryou S.
    J Gynecol Oncol; 2024 Sep; 35(5):e56. PubMed ID: 38330379
    [Abstract] [Full Text] [Related]

  • 36. Diagnostic value of human papillomavirus (HPV) 16 and HPV18 viral loads for the detection of high-grade cervical intraepithelial neoplasia (CIN2+) in a cohort of African women living with HIV.
    Segondy M, Ngou J, Kelly H, Omar T, Goumbri-Lompo O, Doutre S, Mayaud P, Didelot MN.
    J Clin Virol; 2018 Sep; 99-100():79-83. PubMed ID: 29353074
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [To analyse the histopathological results of patients with HPV16/18 positive and colposcopic suspicious lesions].
    Zhang JX, Zheng TP, Liu J, Wang QX, Zhan YX, Zhang ZY.
    Zhonghua Fu Chan Ke Za Zhi; 2017 Jul 25; 52(7):467-472. PubMed ID: 28797154
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.
    Joura EA, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris D, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Miller D, Monsonego J, Munoz N, Myers E, Paavonen J, Pitisuttithum P, Steben M, Wheeler CM, Perez G, Saah A, Luxembourg A, Sings HL, Velicer C.
    Cancer Epidemiol Biomarkers Prev; 2014 Oct 25; 23(10):1997-2008. PubMed ID: 25274978
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.